These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6795230)

  • 1. Selective effects of glucocerebroside (Gaucher's storage material) on macrophage cultures.
    Gery I; Zigler JS; Brady RO; Barranger JA
    J Clin Invest; 1981 Nov; 68(5):1182-9. PubMed ID: 6795230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of rates of hydrolysis of N-oleoyl and N-stearoyl glucocerebroside in patients with Gaucher's disease.
    Peters SP; Aquino L; Naccarato WF; Gilbertson JR; Diven WF; Glew RH
    Biochim Biophys Acta; 1979 Oct; 575(1):27-36. PubMed ID: 508779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of the effect of chrysotile, quartz and rutile on the release of lymphocyte-activating factor (interleukin 1) by murine peritoneal macrophages in vitro.
    Godelaine D; Beaufay H
    IARC Sci Publ; 1989; (90):149-55. PubMed ID: 2545603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between production and release of lymphocyte-activating factor (interleukin 1) by murine macrophages. 1. Effects of various agents.
    Gery I; Davies P; Derr J; Krett N; Barranger JA
    Cell Immunol; 1981 Nov; 64(2):293-303. PubMed ID: 6272997
    [No Abstract]   [Full Text] [Related]  

  • 5. Gaucher's disease.
    Patel AL; Shaikh WA; Khobragade AK; Soni HG; Joshi AS; Sahasrabudhe GS; Chole PV
    J Assoc Physicians India; 2009 May; 57():410-1. PubMed ID: 19634291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
    Barton NW; Brady RO; Dambrosia JM; Di Bisceglie AM; Doppelt SH; Hill SC; Mankin HJ; Murray GJ; Parker RI; Argoff CE
    N Engl J Med; 1991 May; 324(21):1464-70. PubMed ID: 2023606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular translocation of fluorescent sphingolipids in cultured fibroblasts: endogenously synthesized sphingomyelin and glucocerebroside analogues pass through the Golgi apparatus en route to the plasma membrane.
    Lipsky NG; Pagano RE
    J Cell Biol; 1985 Jan; 100(1):27-34. PubMed ID: 3965473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease.
    Vitner EB; Farfel-Becker T; Eilam R; Biton I; Futerman AH
    Brain; 2012 Jun; 135(Pt 6):1724-35. PubMed ID: 22566609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. THE METABOLISM OF GLUCOCEREBROSIDES. I. PURIFICATION AND PROPERTIES OF A GLUCOCEREBROSIDE-CLEAVING ENZYME FROM SPLEEN TISSUE.
    BRADY RO; KANFER J; SHAPIRO D
    J Biol Chem; 1965 Jan; 240():39-43. PubMed ID: 14253443
    [No Abstract]   [Full Text] [Related]  

  • 10. METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.
    BRADY RO; KANFER JN; SHAPIRO D
    Biochem Biophys Res Commun; 1965 Jan; 18():221-5. PubMed ID: 14282020
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver.
    Owada M; Sakiyama T; Kitagawa T
    Pediatr Res; 1977 May; 11(5):641-6. PubMed ID: 870871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal and cellular models of Gaucher's disease. I. Refractoriness of thio analogs of glucocerebroside to enzymatic hydrolysis.
    Quirk JM; Weis AL; Shapiro D; Brady RO
    Biotechnol Appl Biochem; 1986 Feb; 8(1):96-100. PubMed ID: 3828086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS.
    Mizel SB; Oppenheim JJ; Rosentreich DL
    J Immunol; 1978 May; 120(5):1504-8. PubMed ID: 307016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
    Glew RH; Daniels LB; Clark LS; Hoyer SW
    J Neuropathol Exp Neurol; 1982 Nov; 41(6):630-41. PubMed ID: 6813430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha production.
    Renier G; Clément I; Desfaits AC; Lambert A
    Endocrinology; 1996 Nov; 137(11):4611-8. PubMed ID: 8895324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10.
    Allen MJ; Myer BJ; Khokher AM; Rushton N; Cox TM
    QJM; 1997 Jan; 90(1):19-25. PubMed ID: 9093585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors.
    Moore RN; Oppenheim JJ; Farrar JJ; Carter CS; Waheed A; Shadduck RK
    J Immunol; 1980 Sep; 125(3):1302-5. PubMed ID: 6774016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).
    Mizel SB; Dayer JM; Krane SM; Mergenhagen SE
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2474-7. PubMed ID: 6264478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dialysis procedure for loading erythrocytes with enzymes and lipids.
    Deloach J; Ihler G
    Biochim Biophys Acta; 1977 Jan; 496(1):136-45. PubMed ID: 836891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile Gaucher's disease: a case with neuronal storage.
    Grafe M; Thomas C; Schneider J; Katz B; Wiley C
    Ann Neurol; 1988 Mar; 23(3):300-3. PubMed ID: 2837134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.